Jamieson Corporate Finance advised a top-class management team led by Magnus Lundberg in their secondary buy-out of Phadia (formerly Pharmacia Diagnostics). Cinven won a fiercely competitive auction to buy the global leader in allergy diagnostics from PPM and Triton.
Phadia is a unique business at the forefront of systems to support the clinical diagnosis and monitoring of allergy and autoimmune diseases. Phadia’s products are sold under the Immunocap brand into more than 3000 laboratories in 60 countries.
The team at Jamieson Corporate Finance, Ian and Eileen Jamieson, Adam Hall and Feilim McCole have advised management throughout the sales process helping not only to negotiate management terms but also to ensure that the globally dispersed management team were fully involved in the process.
“We are pleased that we engaged the Jamieson team to advise us during the process. Their knowledge and experience of private equity matters and investors was clearly evident from an early stage. They quickly became a trusted source of professionally delivered independent advice for our management team. We were impressed at how effectively they dealt with our exiting owners and a wide geographical spread of potential future owners of Phadia on our behalf and how at all times they remained solely focused on our best interests. They more than met our expectations and really helped us to achieve the outcome we wanted.”
Magnus Lundberg, CEO
